A market interest rate decline could also reduce our return on investments that do not support particular policy obligations.If we do not pay dividends on our preferred stock or pay interest on our junior subordinated debentures or trust securities, terms of those instruments may restrict our ability to pay dividends on or repurchase our common stock.Additionally, the change in value of underlying collateral within mortgage-backed securities, asset-backed securities (“ ABS”) and collateralized loan obligations (“ CLO”) may result in a default on principal and interest payments, reducing our cash flows.We May Be Unable to Access Our Credit Facility, Reducing Our Liquidity and Leading to Downgrades in Our Credit and Financial Strength RatingsWe may fail to comply with or fulfill all conditions under the unsecured revolving credit facility (the“ Credit Facility”) MetLife, Inc. and MetLife Funding, Inc. (“ MetLife Funding”) maintain.In June 2022, we announced our goal to achieve net zero greenhouse gas emissions for our global operations and general account investment portfolio by 2050 or sooner.Our success in conducting business through joint ventures will depend on our ability to manage a variety of issues, including: (i) our exposure to additional operational, financial, legal, tax or compliance risks as a result of entry into certain joint ventures; (ii) our dependence on a joint venture counterparty given limits on our ownership or distribution requirements, as well as for resources, including capital and product distribution, may reduce our control over, financial returns from, or the value of a joint venture; and (iii) our counterparties'cooperation or their ability to meet obligations, or election to alter, modify or terminate a relationship.Declining equity or debt markets may decrease the account value of our products, reducing certain fees generated by these products, which may increase the level of insurance liabilities we carry and require us to increase funding to our captive reinsurers.During certain market events, such as a global credit crisis, a market downturn, or sustained low market returns, we may incur significant losses due to, among other reasons, losses incurred in our general account and the impact of guarantees, including increases in liabilities, capital maintenance obligations and collateral requirements.Capital and credit market volatility may limit our access to capital we need to operate, limiting our ability to raise capital, issue the types of securities we would prefer, timely replace maturing liabilities, satisfy regulatory requirements, and access capital to grow our business, any of which could decrease our profitability and significantly reduce our financial flexibility.We may incur costs to comply with laws and regulations and changes to these laws and regulations may increase our expenses and regulatory capital charges.Changes in regulatory approval processes, rules and other dynamics in the regulatory process could harm our ability to react to such changing conditions.This may increase uncertainty, prolong deleterious regulations and policies, delay or prevent beneficial regulatory or policy changes, and create the potential for later, more rapid changes to which we find it more difficult to adjust.We may face moratoriums on foreclosures and other enforcement actions impairments, and loan or lease modifications, due to government action or market conditions.Expanding our operations to new businesses or jurisdictions may require considerable management time and expenses before significant, if any, revenues and earnings are generated, which may reduce management and financial resources available for other uses.Technological changes may affect our business model and how we interact with existing or prospective customers, and evolving consumer preferences may require a redesign of our products and investment composition.Our derivatives and other risk management strategies to hedge our economic exposure to these liabilities may harm our results.Pandemics and other public health issues (such as the COVID-19 pandemic) have increased, and may continue to increase, our administrative expenses and have impacted the reliability and efficacy of our operational processes.Our continuous technological evaluations and enhancements, including changes designed to update our protective measures, may increase our risk of a breach or gap in our security.For purposes of the two hypothetical interest rate scenarios, we have excluded all VA program derivatives.An LTV ratio greater than 100% indicates that the loan amount is greater than the collateral value.An LTV ratio of less than 100% indicates an excess of collateral value over the loan amount.See“ Business—Segments and Corporate & Other” and Note 2 of the Notes to the Consolidated Financial Statements for further information on the Company’ s segments and Corporate & Other.61 Table of ContentsSummary of Critical Accounting Estimates The preparation of financial statements in conformity with GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the Consolidated Financial Statements.See Notes 5 and 16 of the Notes to the Consolidated Financial Statements for information regarding the DAC and VOBA offset to unrealized investment gains (losses).The evaluation processes, measurement methodologies, significant inputs and significant judgments and assumptions used to determine the amount of credit loss are described in Notes 1 and 8 of the Notes to the Consolidated Financial Statements.The ACL methodologies, significant inputs and significant judgements and assumptions used to determine the amount of credit loss are described in Notes 1 and 8 of the Notes to the Consolidated Financial Statements.The evaluation processes, measurement methodologies, significant inputs and significant judgments and assumptions used to determine the amount of ACL and impairments are described in Notes 1 and 8 of the Notes to the Consolidated Financial Statements.DispositionsDisposition of MetLife Poland and GreeceFor information regarding the Company's dispositions of its wholly-owned subsidiaries in Poland and Greece in April 2022 and January 2022, respectively, which were reported as held-for-sale, see Notes 1 and 3 of the Notes to the Consolidated Financial Statements.Disposition of MetLife P & CFor information regarding the Company's April 2021 disposition of MetLife P & C, which was reported as held-for-sale, see Notes 1 and 3 of the Notes to the Consolidated Financial Statements.(1) See“ Financial Measures and Segment Accounting Policies” in Note 2 of the Notes to the Consolidated Financial Statements for a discussion of the adjustments made to net investment income under GAAP in calculating adjusted net investment income.(5) See“ Financial Measures and Segment Accounting Policies” in Note 2 of the Notes to the Consolidated Financial Statements for discussion of divested businesses.See Note 10 of the Notes to the Consolidated Financial Statements for a discussion of the types of market standard valuation methodologies utilized and key assumptions and observable inputs used in applying these standard valuation methodologies.See Note 10 of the Notes to the Consolidated Financial Statements for valuation approaches and key inputs by major category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy.See Notes 1 and 8 of the Notes to the Consolidated Financial Statements for further information about the secured borrowings accounting and the classification of revenues and expenses.See“—Mortgage Loan Credit Quality—Monitoring Process” for further information and Note 8 of the Notes to the Consolidated Financial Statements for a distribution of our commercial mortgage loans by DSCR and LTV ratios.See Notes 1 and 8 of the Notes to the Consolidated Financial Statements for information on how the ACL is established and monitored, and activity in and balances of the ACL. Real Estate and Real Estate Joint VenturesOur real estate investments are comprised of wholly-owned properties, and interests in both real estate joint ventures and real estate funds which invest in a wide variety of properties and property types, including single and multi-property projects, and broadly diversified across multiple property types and geographies.See Note 21 of the Notes to the Consolidated Financial Statements for the amount of our unfunded investment commitments at December 31, 2022 and 2021.See“ Net Investment Income” and“ Net Investment Gains (Losses)” in Note 8 of the Notes to the Consolidated Financial Statements for information on the investment income, investment expense, gains and losses from such investments and the liability for credit loss for unfunded mortgage loan commitments.See Note 9 of the Notes to the Consolidated Financial Statements for: • A comprehensive description of the nature of our derivatives, including the strategies for which derivatives are used in managing various risks.Fair Value HierarchySee Note 10 of the Notes to the Consolidated Financial Statements for derivatives measured at estimated fair value on a recurring basis and their corresponding fair value hierarchy.104 Table of ContentsCredit RiskSee Note 9 of the Notes to the Consolidated Financial Statements for information about how we manage credit risk related to derivatives and for the estimated fair value of our net derivative assets and net derivative liabilities after the application of master netting agreements and collateral.We calculate in-the-moneyness with respect to GMIBs consistent with net amount at risk as discussed in Note 4 of the Notes to the Consolidated Financial Statements, by comparing the contractholders’ income benefits based on total account values and current annuity rates versus the guaranteed income benefits.See also Note 16 of the Notes to the Consolidated Financial Statements for information regarding MetLife, Inc.’ s common stock repurchase authorizations.See Note 5 of the Notes to the MetLife, Inc. (Parent Company Only) Condensed Financial Information included in Schedule II of the Financial Statement Schedules for further details on certain of these support arrangements.Policyholder Account BalancesSee Notes 1 and 4 of the Notes to the Consolidated Financial Statements for a description of the components of policyholder account balances.Credit and Committed FacilitiesSee Note 13 of the Notes to the Consolidated Financial Statements for information on credit and committed facilities.DispositionsSee“—Acquisitions and Dispositions” and Note 3 of the Notes to the Consolidated Financial Statements for information on the Company’ s business dispositions.See Notes 13 and 14 of the Notes to the Consolidated Financial Statements for further information on long-term and short-term debt and the collateral financing arrangement, respectively.See Note 5 of the Notes to the MetLife, Inc. (Parent Company Only) Condensed Financial Information included in Schedule II of the Financial Statement Schedules.Insurance LiabilitiesInsurance liabilities include future policy benefits, other policy-related balances, policyholder dividends payable and the policyholder dividend obligation, which are all reported on the consolidated balance sheet and are more fully described in Notes 1 and 4 of the Notes to the Consolidated Financial Statements.See Note 9 of the Notes to the Consolidated Financial Statements for additional information about collateral pledged to us, collateral we pledge and derivatives subject to credit contingent provisions.123 Table of ContentsAcquisitionsSee“—Acquisitions and Dispositions” and Note 3 of the Notes to the Consolidated Financial Statements for information on the Company’ s business acquisitions.(5) See MetLife, Inc. (Parent Company Only) Condensed Statements of Cash Flows included in Schedule II of the Financial Statement Schedules for information regarding the source of liquid assets from receipts on loans to subsidiaries (excluding interest) and the use of liquid assets related to the issuances of loans to subsidiaries (excluding interest).Collateral Financing Arrangement and Junior Subordinated Debt SecuritiesFor information on MetLife, Inc.’ s collateral financing arrangement and junior subordinated debt securities, see Notes 14 and 15 of the Notes to the Consolidated Financial Statements, respectively.127 Table of ContentsCredit and Committed FacilitiesSee Note 13 of the Notes to the Consolidated Financial Statements for further information regarding the Company’ s Credit Facility and certain committed facilities.See Note 5 of the Notes to the MetLife, Inc. (Parent Company Only) Condensed Financial Information included in Schedule II of the Financial Statement Schedules.For information relating to adjusted revenues and adjusted expenses, see“ Financial Measures and Segment Accounting Policies” in Note 2 of the Notes to the Consolidated Financial Statements.For further information, see“ Financial Measures and Segment Accounting Policies” in Note 2 of the Notes to the Consolidated Financial Statements.Subsequent EventsSee“—Acquisitions and Dispositions” and Note 22 of the Notes to the Consolidated Financial Statements.